These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 35323951

  • 1. Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational Cohort.
    Lu Y, Van Zandt M, Liu Y, Li J, Wang X, Chen Y, Chen Z, Cho J, Dorajoo SR, Feng M, Hsu MH, Hsu JC, Iqbal U, Jonnagaddala J, Li YC, Liaw ST, Lim HS, Ngiam KY, Nguyen PA, Park RW, Pratt N, Reich C, Rhee SY, Sathappan SMK, Shin SJ, Tan HX, You SC, Zhang X, Krumholz HM, Suchard MA, Xu H.
    JAMA Netw Open; 2022 Mar 01; 5(3):e223877. PubMed ID: 35323951
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin Receptor Blockers for Hypertension and Risk of Epilepsy.
    Wen X, Otoo MN, Tang J, Brothers T, Ward KE, Asal N, Meador KJ.
    JAMA Neurol; 2024 Aug 01; 81(8):866-874. PubMed ID: 38884986
    [Abstract] [Full Text] [Related]

  • 3. [Assessment of antihypertensive monotherapies effectiveness by home blood pressure self-measurement in hypertensive patients].
    Hanon O, Laroche P, Vidal JS, Pannier B, Postel-Vinay N, Vaisse B, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun 01; 61(3):218-23. PubMed ID: 22695025
    [Abstract] [Full Text] [Related]

  • 4. Outcomes of Hospitalized COVID-19 Patients Receiving Renin Angiotensin System Blockers and Calcium Channel Blockers.
    Choksi TT, Zhang H, Chen T, Malhotra N.
    Am J Nephrol; 2021 Jun 01; 52(3):250-260. PubMed ID: 33827074
    [Abstract] [Full Text] [Related]

  • 5. First line drug treatment for hypertension and reductions in blood pressure according to age and ethnicity: cohort study in UK primary care.
    Sinnott SJ, Douglas IJ, Smeeth L, Williamson E, Tomlinson LA.
    BMJ; 2020 Nov 18; 371():m4080. PubMed ID: 33208355
    [Abstract] [Full Text] [Related]

  • 6. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS, Tang CH, Lin CY, Chuang PY, Chen NC, Huang CH, Chang WT, Wang TD, Yu PH, Chen WJ.
    Cardiovasc Drugs Ther; 2017 Dec 18; 31(5-6):535-543. PubMed ID: 29218625
    [Abstract] [Full Text] [Related]

  • 7. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL, King JB, Oparil S, Wright JT, Ogedegbe G, Mohanty A, Hardy ST, Huang L, Hess R, Muntner P, Bress A.
    JAMA Netw Open; 2020 Nov 02; 3(11):e2025127. PubMed ID: 33206191
    [Abstract] [Full Text] [Related]

  • 8. Long-term comparative effectiveness of antihypertensive monotherapies in primary prevention of cardiovascular events: a population-based retrospective inception cohort study in the Netherlands.
    Li X, Bijlsma MJ, Bos JHJ, Schuiling-Veninga CCM, Hak E.
    BMJ Open; 2023 Aug 09; 13(8):e068721. PubMed ID: 37558444
    [Abstract] [Full Text] [Related]

  • 9. Renoprotective Effect of the Combination of Renin-angiotensin System Inhibitor and Calcium Channel Blocker in Patients with Hypertension and Chronic Kidney Disease.
    Huang RS, Cheng YM, Zeng XX, Kim S, Fu P.
    Chin Med J (Engl); 2016 Mar 05; 129(5):562-9. PubMed ID: 26904991
    [Abstract] [Full Text] [Related]

  • 10. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
    Doege C, Luedde M, Kostev K.
    JAMA Neurol; 2022 Dec 01; 79(12):1296-1302. PubMed ID: 36251288
    [Abstract] [Full Text] [Related]

  • 11. Temporal trend of first-line drug choice and treatment continuity for hypertension among citizens 75 years or over - a register-based, cohort study.
    Nielsen SK, Lamberts M, Nouhravesh N, Jensen MH, Strange JE, Gislason G, Mcgettigan P, Holt A.
    Int J Cardiol; 2024 Aug 01; 408():132137. PubMed ID: 38705205
    [Abstract] [Full Text] [Related]

  • 12. Real-World Effectiveness of Beta-Blockers versus Other Antihypertensives in Reducing All-Cause Mortality and Cardiovascular Events.
    Foch C, Allignol A, Hostalek U, Boutmy E, Hohenberger T.
    Int J Clin Pract; 2022 Aug 01; 2022():6124559. PubMed ID: 35989866
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Frequency and Patterns of Prescribing Antihypertensive Agents in Outpatient Kidney Transplant Recipients Among Six Cities in China from 2011 to 2018.
    Hou W, Li D, Shen S, Lin J, Lou A, Wen A.
    Clin Ther; 2021 Mar 01; 43(3):602-612. PubMed ID: 33637331
    [Abstract] [Full Text] [Related]

  • 15. Analysis of second- and third-line antihypertensive treatments after initial therapy with an angiotensin II receptor blocker using real-world Japanese data.
    Hiroi S, Shimasaki Y, Kikuchi T, Otsuka Y, Iwasaki K, Ohishi M.
    Hypertens Res; 2016 Dec 01; 39(12):907-912. PubMed ID: 27465576
    [Abstract] [Full Text] [Related]

  • 16. Development and Validation of a Medication Selection Model Under Clinical Application of Renin-Angiotensin Inhibitor Combined with Calcium Channel Blocker for Hypertension Patients.
    Hong D, Shi W, Lu X, Lou Y, Li L.
    Med Sci Monit; 2020 Apr 14; 26():e923696. PubMed ID: 32285846
    [Abstract] [Full Text] [Related]

  • 17. Prescription pattern of antihypertensive medications and blood pressure control among hypertensive outpatients at the University of Benin Teaching Hospital in Benin City, Nigeria.
    Adejumo O, Okaka E, Iyawe I.
    Malawi Med J; 2017 Jun 14; 29(2):113-117. PubMed ID: 28955417
    [Abstract] [Full Text] [Related]

  • 18. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
    Smith SM, Winterstein AG, Gurka MJ, Walsh MG, Keshwani S, Libby AM, Hogan WR, Pepine CJ, Cooper-DeHoff RM.
    J Am Heart Assoc; 2023 Jan 03; 12(1):e026652. PubMed ID: 36565195
    [Abstract] [Full Text] [Related]

  • 19. Choice of antihypertensive medications among physicians and its impact on blood pressure control among Nigerians living with hypertension.
    Mijinyawa Muhammad S, Yusuf MS, Mohammed H, Saidu H, Sulaiman BA, Uloko AE.
    Niger J Med; 2016 Jan 03; 25(3):220-5. PubMed ID: 30011166
    [Abstract] [Full Text] [Related]

  • 20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ, Ishola DA, Akintomide AO, Ajayi AA.
    J Hum Hypertens; 2003 Apr 03; 17(4):277-85. PubMed ID: 12714973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.